These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26964533)

  • 1. MicroRNAs in colorectal carcinoma--from pathogenesis to therapy.
    Chi Y; Zhou D
    J Exp Clin Cancer Res; 2016 Mar; 35():43. PubMed ID: 26964533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA: A new player in response to therapy for colorectal cancer.
    Sarvizadeh M; Malekshahi ZV; Razi E; Sharifi H; Moussavi N; Taghizadeh M
    J Cell Physiol; 2019 Jun; 234(6):8533-8540. PubMed ID: 30478837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).
    Jin D; Fang Y; Li Z; Chen Z; Xiang J
    Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication.
    Moradi Marjaneh R; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    IUBMB Life; 2019 Oct; 71(10):1428-1441. PubMed ID: 31322820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs: Clinical Relevance in Colorectal Cancer.
    Thomas J; Ohtsuka M; Pichler M; Ling H
    Int J Mol Sci; 2015 Nov; 16(12):28063-76. PubMed ID: 26602923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in colorectal cancer: potential biomarkers and therapeutic targets.
    Yan S; Cao Y; Mao A
    Front Biosci (Landmark Ed); 2015 Jun; 20(7):1092-103. PubMed ID: 25961547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms.
    Marjaneh RM; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    J Cell Physiol; 2019 Mar; 234(3):2306-2316. PubMed ID: 30191973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
    Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
    Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
    Valeri N; Croce CM; Fabbri M
    Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer.
    Andreoli SC; Gasparini NJ; de Carvalho GP; Garicochea B; Pogue RE; de Andrade RV
    Einstein (Sao Paulo); 2014 Apr; 12(2):256-8. PubMed ID: 25003938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNAs in colorectal cancer.
    Schetter AJ; Okayama H; Harris CC
    Cancer J; 2012; 18(3):244-52. PubMed ID: 22647361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical
    Weidle UH; Brinkmann U; Auslaender S
    Cancer Genomics Proteomics; 2020; 17(5):453-468. PubMed ID: 32859626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression.
    Shen Z; Zhou R; Liu C; Wang Y; Zhan W; Shao Z; Liu J; Zhang F; Xu L; Zhou X; Qi L; Bo F; Ding Y; Zhao L
    Cell Death Dis; 2017 Dec; 8(12):3213. PubMed ID: 29238068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.